(Q48064172)

English

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.

scientific article published on 30 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25269831

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25269831

Behçet's disease

0 references

Simon R. Taylor

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Oren Tomkins-Netzer

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

S Lightman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

H Longhurst

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

W Lynn

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

R Moots

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Stanford

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

D Yang

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

V L Calder

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

D O Haskard

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

0 references

publication date

30 September 2014

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/25269831

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

74

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1138-1144

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A controlled trial of azathioprine in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Behçet's disease.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Behçet's disease: ocular effects and treatment

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Development of a fatigue scale.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Behçet's disease: evaluation of a new instrument to measure clinical activity.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Regulatory T cells inhibit acute IFN-γ synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Possible mechanisms of neutrophil activation in Behçet's disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Therapeutic potential of Tregs to treat rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Regulatory T cells and other lymphocyte subpopulations in patients with melanoma developing interferon-induced thyroiditis during high-dose interferon-α2b treatment.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

CD4+CD25+Foxp3+ regulatory T cells contribute in liver fibrosis improvement with interferon alpha

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4⁺CD25⁺Foxp3⁺ regulatory T cells in COPD.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Pathological implications of Th1/Th2 cytokine genetic variants in Behçet's disease: Data from a pilot study in a Sicilian population.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Current and future treatments for Behçet's uveitis: road to remission

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Cytokines and Behcet's disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205571

21 January 2018

Identifiers

10.1136/ANNRHEUMDIS-2014-205571

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25269831%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48064172&oldid=1198384458"